Target type: biologicalprocess
Any process that activates or increases the frequency, rate or extent of gamma-delta T cell activation. [GOC:ai]
Positive regulation of gamma-delta T cell activation is a complex process involving a series of molecular interactions that ultimately lead to the activation and differentiation of these specialized immune cells. Gamma-delta T cells, unlike their alpha-beta counterparts, recognize a wide range of antigens, including non-peptide antigens presented by non-classical MHC molecules, as well as stress-induced molecules expressed by infected or transformed cells. This broad recognition capability makes gamma-delta T cells crucial players in innate immunity and early immune responses.
The activation of gamma-delta T cells is initiated by the engagement of their TCR with specific ligands. This interaction triggers a cascade of intracellular signaling events, ultimately leading to the activation of transcription factors, such as NF-κB and AP-1, which induce the expression of genes involved in cell proliferation, differentiation, and effector function.
Several factors contribute to the positive regulation of gamma-delta T cell activation:
- **Ligand-mediated signaling:** Engagement of the TCR with its ligand initiates signaling cascades that are essential for activation. This involves the phosphorylation of intracellular signaling molecules, such as ZAP-70 and Lck, and the subsequent activation of downstream pathways like the MAPK and PI3K pathways.
- **Costimulatory signals:** In addition to TCR engagement, gamma-delta T cells require costimulatory signals from other immune cells or molecules. These signals are often delivered through molecules like CD28 and CD2, which bind to their ligands expressed on antigen-presenting cells. Costimulatory signals amplify TCR-mediated signaling and contribute to the full activation of gamma-delta T cells.
- **Cytokine signaling:** Cytokines play a crucial role in regulating the activation and differentiation of gamma-delta T cells. Interleukin-2 (IL-2), IL-15, and IL-18 are examples of cytokines that can positively regulate gamma-delta T cell activation by promoting their proliferation and differentiation into effector cells.
- **Microenvironment:** The surrounding environment, including the presence of other immune cells and the expression of specific molecules, can influence the activation of gamma-delta T cells. For instance, the presence of dendritic cells (DCs) and macrophages can enhance the activation of gamma-delta T cells by providing costimulatory signals and presenting antigens.
Once activated, gamma-delta T cells differentiate into effector cells that can perform various functions, including:
- **Cytotoxicity:** Some gamma-delta T cells become cytotoxic and directly kill infected or tumor cells through the release of cytotoxic granules containing molecules like granzyme B and perforin.
- **Cytokine production:** Gamma-delta T cells can produce various cytokines, including IFN-γ, TNF-α, and IL-17, which play important roles in inflammation, immune regulation, and the recruitment of other immune cells.
- **Antigen presentation:** Some gamma-delta T cells can act as antigen-presenting cells, capturing antigens and presenting them to other immune cells, contributing to the development of adaptive immune responses.
The positive regulation of gamma-delta T cell activation is a highly regulated process that is crucial for maintaining immune homeostasis and responding effectively to diverse threats, including infections, cancer, and autoimmunity.'
"
Protein | Definition | Taxonomy |
---|---|---|
Nucleotide-binding oligomerization domain-containing protein 2 | A nucleotide-binding oligomerization domain-containing protein 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9HC29] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
paclitaxel | Taxus: Genus of coniferous yew trees or shrubs, several species of which have medicinal uses. Notable is the Pacific yew, Taxus brevifolia, which is used to make the anti-neoplastic drug taxol (PACLITAXEL). | taxane diterpenoid; tetracyclic diterpenoid | antineoplastic agent; human metabolite; metabolite; microtubule-stabilising agent |
docetaxel anhydrous | docetaxel anhydrous : A tetracyclic diterpenoid that is paclitaxel with the N-benzyloxycarbonyl group replaced by N-tert-butoxycarbonyl, and the acetoxy group at position 10 replaced by a hydroxy group. Docetaxel: A semisynthetic analog of PACLITAXEL used in the treatment of locally advanced or metastatic BREAST NEOPLASMS and NON-SMALL CELL LUNG CANCER. | secondary alpha-hydroxy ketone; tetracyclic diterpenoid | antimalarial; antineoplastic agent; photosensitizing agent |
muramyl dipeptide | glycopeptide | immunological adjuvant | |
3-methyl-7-pentyl-8-(2-phenylethylthio)purine-2,6-dione | oxopurine | ||
3-methyl-7-(phenylmethyl)-8-(propan-2-ylthio)purine-2,6-dione | oxopurine | ||
1-(4-methylphenyl)sulfonyl-2-benzimidazolamine | sulfonamide | ||
1-(4-chlorophenyl)sulfonyl-2-benzimidazolamine | sulfonamide | ||
1-(benzenesulfonyl)-2-benzimidazolamine | sulfonamide | ||
1-(4-nitrophenyl)sulfonyl-2-benzimidazolamine | sulfonamide | ||
pd 166285 | |||
1-(4-methoxyphenyl)sulfonyl-2-benzimidazolamine | sulfonamide | ||
5,6-dimethyl-1-(4-methylphenyl)sulfonyl-2-benzimidazolamine | sulfonamide |